Literature DB >> 3003154

Decreased leukotriene B4 synthesis in smokers' alveolar macrophages in vitro.

M Laviolette, R Coulombe, S Picard, P Braquet, P Borgeat.   

Abstract

Recent studies have shown that alveolar macrophages (AM) are able to release leukotrienes (LTs). Since cigarette smoking inhibits the cyclooxygenase pathway of arachidonic acid metabolism in the AM, we evaluated the LT production by AM from smokers and nonsmokers. AM were obtained from 35 volunteers, 16 nonsmokers, and 19 smokers. The cells were incubated under various conditions including stimulation with 30 microM arachidonic acid, 2 microM ionophore A23187, or both. Each experiment was performed in parallel using cells from a smoker and a nonsmoker. Lipoxygenase products were analyzed by reverse-phase high performance liquid chromatography. After stimulation, nonsmokers' AM produced LTB4 and 5-hydroxy-eicosatetraenoic acid (5-HETE). In incubations of AM with arachidonic acid and ionophore, the amounts of products formed were: LTB4, 317 +/- 56 pmol/10(6) cells and 5-HETE, 1,079 +/- 254, mean +/- SEM. No metabolites were generated under control conditions (no stimulation). In all incubations performed, the peptido-LTs (LTC4, LTD4, and LTE4) were undetectable. In comparison with AM from nonsmokers, those from smokers showed a 80-90% reduction of 5-HETE and LTB4 synthesis (P less than 0.05 to P less than 0.001 according to stimulatory conditions). This defective lipoxygenase metabolite production in AM from smokers was observed over a wide range of stimuli concentrations and incubation times; AM from smokers also had lower levels of intracellular (esterified) 5-HETE than nonsmokers' AM. We also studied blood polymorphonuclear leukocytes (PMNL) and no difference in the synthesis of 5-lipoxygenase products in these cells was noticed between smokers and nonsmokers. These data show that cigarette smoking causes a profound inhibition of the 5-lipoxygenase pathway in AM but not in blood PMNL.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003154      PMCID: PMC423308          DOI: 10.1172/JCI112301

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  The ultrastructure of alveolar macrophages from human cigarette smokers and nonsmokers.

Authors:  S A Pratt; M H Smith; A J Ladman; T N Finley
Journal:  Lab Invest       Date:  1971-05       Impact factor: 5.662

2.  Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.

Authors:  J A Kazmierowski; J I Gallin; H Y Reynolds
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

3.  Histochemical staining and in vitro spreading of human pulmonary alveolar macrophages: variability with cigarette smoking status.

Authors:  G A Warr; R R Martin
Journal:  J Reticuloendothel Soc       Date:  1978-01

4.  Smoking habit and incidence of respiratory tract infections in a group of adolescent males.

Authors:  W F Haynes; V J Krstulovic; A L Bell
Journal:  Am Rev Respir Dis       Date:  1966-05

5.  Cigarette smoking and respiratory infections in a class of student nurses.

Authors:  J L Parnell; D O Anderson; C Kinnis
Journal:  N Engl J Med       Date:  1966-05-05       Impact factor: 91.245

Review 6.  Defense mechanisms of the respiratory membrane.

Authors:  G M Green; G J Jakab; R B Low; G S Davis
Journal:  Am Rev Respir Dis       Date:  1977-03

7.  Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.

Authors:  P Borgeat; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

8.  Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid.

Authors:  P Borgeat; B Samuelsson
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

9.  Metabolism of arachidonic acid in ionophore-stimulated neutrophils. Esterification of a hydroxylated metabolite into phospholipids.

Authors:  W F Stenson; C W Parker
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

10.  Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers.

Authors:  J O Harris; E W Swenson; J E Johnson
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

View more
  19 in total

1.  Smoking, humoral immunity, and ulcerative colitis.

Authors:  E D Srivastava; J R Barton; S O'Mahony; D I Phillips; G T Williams; N Matthews; A Ferguson; J Rhodes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosis.

Authors:  V De Rose; L Trentin; M T Crivellari; A Cipriani; G Gialdroni Grassi; E Pozzi; G Folco; G Semenzato
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

Review 3.  Immune and inflammatory function in cigarette smokers.

Authors:  P G Holt
Journal:  Thorax       Date:  1987-04       Impact factor: 9.139

4.  Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan.

Authors:  J A Rankin; I Sylvester; S Smith; T Yoshimura; E J Leonard
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma.

Authors:  Pankaj K Bhavsar; Bruce D Levy; Mark J Hew; Michael A Pfeffer; Shamsah Kazani; Elliot Israel; Kian Fan Chung
Journal:  Respir Res       Date:  2010-06-07

6.  Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.

Authors:  R C Hubbard; G Fells; J Gadek; S Pacholok; J Humes; R G Crystal
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

7.  5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae.

Authors:  P Mancuso; T J Standiford; T Marshall; M Peters-Golden
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

8.  Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.

Authors:  Hekun Jin; Susan L Tucker; Hui Helen Liu; Xiong Wei; Sue Sun Yom; Shulian Wang; Ritsuko Komaki; Yuhchyau Chen; Mary K Martel; Radhe Mohan; James D Cox; Zhongxing Liao
Journal:  Radiother Oncol       Date:  2008-10-18       Impact factor: 6.280

9.  Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins.

Authors:  B D Levy; M Romano; H A Chapman; J J Reilly; J Drazen; C N Serhan
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Leukotriene generation and metabolism in isolated human lung macrophages.

Authors:  W Schönfeld; B Schlüter; R Hilger; W König
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.